These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 420824)

  • 21. Labeling of the active site of alpha-chymotrypsin with N-nitroso-N-benzylacetamide and related compounds.
    Li M; Roswell DF; White EH
    Biochem Biophys Res Commun; 1993 Oct; 196(2):907-13. PubMed ID: 8240368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of the interaction of 4-bromomercuriocinnamic acid with alpha-chymotrypsin by 79 Br and 81Br pulsed nuclear-magnetic resonance.
    Garnett MW; Halstead TK; Hoare DG
    Eur J Biochem; 1976 Jun; 66(1):85-93. PubMed ID: 954747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of derivatives of guanidinophenylglycine and guanidinophenylalanine with trypsin and related enzymes.
    Tsunematsu H; Makisumi S
    J Biochem; 1980 Dec; 88(6):1773-83. PubMed ID: 7462203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMR studies of the alpha-chymotrypsin-(R)-1-acetamido-2-(4-fluorophenyl)ethane-1-boronic acid complex at pH 7.
    Sylvia LA; Gerig JT
    Biochim Biophys Acta; 1995 Oct; 1252(2):225-32. PubMed ID: 7578227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 13C-NMR study of the inhibition of delta-chymotrypsin by a tripeptide-glyoxal inhibitor.
    Djurdjevic-Pahl A; Hewage C; Malthouse JP
    Biochem J; 2002 Mar; 362(Pt 2):339-47. PubMed ID: 11853541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stopped flow fourier transform nuclear magnetic resonance spectroscopy. An application to the alpha-chymotrypsin-catalyzed hydrolysis of tert-butyl-L-phenylalanine.
    Grimaldi JJ; Sykes BD
    J Am Chem Soc; 1975 Jan; 97(2):273-6. PubMed ID: 1133351
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of papain by nitriles: mechanistic studies using NMR and kinetic measurements.
    Liang TC; Abeles RH
    Arch Biochem Biophys; 1987 Feb; 252(2):626-34. PubMed ID: 3813553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMR studies of the alpha-chymotrypsin-(R)-1-acetamido-2-(4- fluorophenyl)ethane-1-boronic acid complex.
    Sylvia LA; Gerig JT
    Biochim Biophys Acta; 1993 Jun; 1163(3):321-34. PubMed ID: 8507671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrolytic inhibition of α-chymotrypsin by 2,8,14,20-tetrakis(D-leucyl-D-valinamido)resorc[4]arenecarboxylic acid: a spectroscopic NMR and computational combined approach.
    Uccello-Barretta G; Balzano F; Aiello F; Vanni L; Mori M; Menta S; Calcaterra A; Botta B
    Org Biomol Chem; 2015 Jan; 13(3):916-24. PubMed ID: 25406985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 13C high-resolution nuclear magnetic resonance studies of enzyme-substrate reactions at equilibrium. Substrate studies of chymotrypsin-N-acetyltyrosine semicarbazide complexes.
    Robillard G; Shaw E; Shulman RG
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2623-6. PubMed ID: 4528121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational dynamics in fluorophenylcarbamoyl-alpha-chymotrypsins.
    Kairi M; Gerig JT
    Biochim Biophys Acta; 1990 Jun; 1039(2):157-70. PubMed ID: 2364092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformations of N-(2-fluorophenyl)-N-phenylcarbamoyl-alpha-chymotrypsin.
    Kairi M; Keder NL; Gerig JT
    Arch Biochem Biophys; 1990 Jun; 279(2):305-14. PubMed ID: 2350178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of chymotrypsin and human skin chymase: kinetics of time-dependent inhibition in the presence of substrate.
    Johnson LA; Moon KE; Eisenberg M
    Biochim Biophys Acta; 1988 Apr; 953(3):269-79. PubMed ID: 2451541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zymogen activation in serine proteinases. Proton magnetic resonance pH titration studies of the two histidines of bovine chymotrypsinogen A and chymotrypsin Aalpha.
    Markley JL; Ibañez IB
    Biochemistry; 1978 Oct; 17(22):4627-40. PubMed ID: 31898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steady-state carbon-13 nuclear magnetic resonance spectra of acyl-alpha-chymotrypsin.
    McWhirter RB; Yevsikov V; Klapper MH
    Biochemistry; 1985 Jun; 24(12):3020-3. PubMed ID: 4016084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 13c NMR studies of the conformation of N-acetyl-L-tryptophan in its complex with chymotrypsin.
    Rodgers P; Roberts GC
    FEBS Lett; 1973 Nov; 36(3):330-3. PubMed ID: 4763311
    [No Abstract]   [Full Text] [Related]  

  • 37. A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond.
    Cassidy CS; Lin J; Frey PA
    Biochemistry; 1997 Apr; 36(15):4576-84. PubMed ID: 9109667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Slow-binding inhibition of chymotrypsin and cathepsin G by the peptide aldehyde chymostatin.
    Stein RL; Strimpler AM
    Biochemistry; 1987 May; 26(9):2611-5. PubMed ID: 3607037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-ketoester-based photobiological switches: synthesis, peptide chain extension and assay against alpha-chymotrypsin.
    Harvey AJ; Abell AD
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2441-4. PubMed ID: 11549442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of alpha-chymotrypsin and Carlsberg subtilisin with methyl N alpha-acetyl-2-(alkylthio)-L-tryptophanoates.
    Yoshizumi K; Kamiyama K; Shieh TC; Tanaka S; Ohno M
    J Biochem; 1986 Nov; 100(5):1201-6. PubMed ID: 3546277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.